OpenAlex
PricingAboutJobs
Log inGet started
Work

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

HTML

Year: 2019
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Lung Cancer
DOI: 10.1016/j.lungcan.2019.05.029
Authors: Urania Dafni, Zoi Tsourti, Katerina Vervita, Solange Peters
Institutions: National and Kapodistrian University of Athens, Centre Hospitalier Universitaire Vaudois, Frontier Science Foundation-Hellas, University of Lausanne
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: immune checkpoint inhibitors, non-small cell lung cancer, first-line therapy, pembrolizumab, atezolizumab, bevacizumab, combination chemotherapy, PD-L1 expression, progression-free survival, overall survival, lung squamous cell carcinoma, non-squamous cell lung cancer, treatment comparison, circumstantial evidence
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2946950110
FWCI: 3.044
Cites: 59
Cited by: 238
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms